Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894917 · ClinicalTrials.gov registry record
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
A clinical trial of Carcinoma, Hepatocellular, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT03894917 is a study of Carcinoma, Hepatocellular that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 84 participants, below the 609-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03894917, a study of Carcinoma, Hepatocellular, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
Conditions Studied
Interventions
- OTHER Comprehensive Geriatric Assessment (CGA)
Study Locations (1)
Texas
- Mays Cancer Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-09-13 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03894917
The ClinicalTrials.gov registry entry for NCT03894917 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (86% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Geriatric Assessment (CGA) is the first listed.
NCT03894917 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03894917 about?
NCT03894917 is a clinical study titled "Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma". This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 year...
What is the current status of trial NCT03894917?
This trial is currently recruiting. The enrollment target is 84 participants. The study started on 2019-09-13. Estimated completion is 2027-12.
What conditions does trial NCT03894917 study?
This clinical trial studies the following conditions: Carcinoma, Hepatocellular.
What interventions are being tested in trial NCT03894917?
The interventions under investigation include: Comprehensive Geriatric Assessment (CGA) (OTHER).
Who is sponsoring clinical trial NCT03894917?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03894917 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Hepatocellular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
RECRUITING · NA
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
RECRUITING · Phase 1
-
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
RECRUITING
-
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.